Table 2.
Creatinine Change Between Different Time Point and Paired T Test.
| Group | Comparison | N | Mean Difference (Group – Comparison) | Paired T test, P value |
|---|---|---|---|---|
| Overall | ||||
| Posttreatment week 4 | Pretreatment | 941 | 0.06 | <0.001 |
| Posttreatment week 24 | Pretreatment | 673 | 0.05 | <0.001 |
| Posttreatment week 24 | Posttreatment week 4 | 673 | −0.006 | 0.6 |
| Sofosbuvir/Ledipasvir-Treated Group | ||||
| Posttreatment week 4 | Pretreatment | 825 | 0.06 | <0.0001 |
| Posttreatment week 24 | Pretreatment | 620 | 0.06 | <0.0001 |
| Posttreatment week 24 | Posttreatment week 4 | 620 | −0.005 | 0.7 |
| Glecaprevir/Pibrentasvir-Treated Group | ||||
| Posttreatment week 4 | Pretreatment | 116 | 0.02 | 0.5 |
| Posttreatment week 24 | Pretreatment | 53 | −0.03 | 0.6 |
| Posttreatment week 24 | Posttreatment week 4 | 53 | −0.01 | 0.8 |